BioLife Solutions Inc (NASDAQ:BLFS) saw an uptick in trading volume on Tuesday after Maxim Group raised their price target on the stock from $6.00 to $7.00. Maxim Group currently has a buy rating on the stock. 659,331 shares traded hands during trading, an increase of 329% from the previous session’s volume of 153,628 shares.The stock last traded at $5.47 and had previously closed at $5.29.

Separately, Janney Montgomery Scott raised shares of BioLife Solutions from a “neutral” rating to a “buy” rating and raised their target price for the stock from $2.62 to $5.00 in a research report on Wednesday, July 5th.

The firm’s market cap is $66.40 million. The stock’s 50-day moving average price is $4.41 and its 200-day moving average price is $2.88.

BioLife Solutions (NASDAQ:BLFS) last announced its earnings results on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06). BioLife Solutions had a negative net margin of 30.03% and a negative return on equity of 64.03%. The firm had revenue of $2.56 million for the quarter, compared to the consensus estimate of $2.40 million. Analysts predict that BioLife Solutions Inc will post ($0.24) EPS for the current year.

TRADEMARK VIOLATION WARNING: This article was first reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Receive News & Ratings for BioLife Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc and related companies with's FREE daily email newsletter.